肺部微生态及其与肺癌关系的研究进展

doi:10.16150/j.1671-2870.2019.05.003

摘要/Abstract

关键词: 肺部微生态, 肺癌, 机制, 进展

中图分类号:

R734.1

刘海霞, 瞿介明. 肺部微生态及其与肺癌关系的研究进展[J]. 诊断学理论与实践, 2019, 18(05): 496-502.

参考文献 59

[1]	Bassis CM, Erb-Downward JR, Dickson RP, et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals[J]. MBio, 2015, 6(2):e00037.
[2]	Marsh RL, Kaestli M, Chang AB, et al. The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx[J]. Microbiome, 2016, 4(1):37. doi: 10.1186/s40168-016-0182-1 pmid: 27388563
[3]	Dickson RP, Huffnagle GB. The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Di-sease[J]. PLoS Pathog, 2015, 11(7):e1004923.
[4]	Morris A, Beck JM, Schloss PD, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smo-kers[J]. Am J Respir Crit Care Med, 2013, 187(10):1067-1075. doi: 10.1164/rccm.201210-1913OC URL
[5]	Budden KF, Shukla SD, Rehman SF, et al. Functional effects of the microbiota in chronic respiratory disease[J]. Lancet Respir Med, 2019, 7(10):907-920. doi: 10.1016/S2213-2600(18)30510-1 URL
[6]	Huang YJ, Lynch SV. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications[J]. Expert Rev Respir Med, 2011, 5(6):809-821. doi: 10.1586/ers.11.76 URL
[7]	Dickson RP, Erb-Downward JR, Huffnagle GB. Homeos-tasis and its disruption in the lung microbiome[J]. Am J Physiol Lung Cell Mol Physiol, 2015, 309(10):L1047-L1055.
[8]	Putinati S, Trevisani L, Gualandi M, et al. Pulmonary infections in lung cancer patients at diagnosis[J]. Lung Cancer, 1994, 11(3-4):243-249. pmid: 7812701
[9]	Belmont L, Rabbe N, Antoine M, et al. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer[J]. Int J Cancer, 2014, 134(4):765-777. doi: 10.1002/ijc.28413 pmid: 23913633
[10]	Chow SC, Gowing SD, Cools-Lartigue JJ, et al. Gram negative bacteria increase non-small cell lung cancer metastasis via Toll-like receptor 4 activation and mitogen-activated protein kinase phosphorylation[J]. Int J Cancer, 2015, 136(6):1341-1350. doi: 10.1002/ijc.29111 URL
[11]	Gomes M, Teixeira AL, Coelho A, et al. The role of inflammation in lung cancer[J]. Adv Exp Med Biol, 2014, 816:1-23.
[12]	Christopoulos A, Saif MW, Sarris EG, et al. Epidemiology of active tuberculosis in lung cancer patients: a systema-tic review[J]. Clin Respir J, 2014, 8(4):375-381. doi: 10.1111/crj.12094 pmid: 24345074
[13]	Boursi B, Mamtani R, Haynes K, et al. Recurrent anti-biotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?[J]. Eur J Cancer, 2015, 51(17):2655-2664. doi: 10.1016/j.ejca.2015.08.015 pmid: 26338196
[14]	Hosgood HD 3rd, Sapkota AR, Rothman N, et al. The potential role of lung microbiota in lung cancer attributed to household coal burning exposures[J]. Environ Mol Mutagen, 2014, 55(8):643-651. doi: 10.1002/em.21878 pmid: 24895247
[15]	Lee SH, Sung JY, Yong D, et al. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions[J]. Lung Cancer, 2016, 102:89-95.
[16]	Yan X, Yang M, Liu J, et al. Discovery and validation of potential bacterial biomarkers for lung cancer[J]. Am J Cancer Res, 2015, 5(10):3111-3122.
[17]	Liu HX, Tao LL, Zhang J, et al. Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects[J]. Int J Cancer, 2018, 142(4):769-778. doi: 10.1002/ijc.31098 URL
[18]	Yu G, Gail MH, Consonni D, et al. Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features[J]. Genome Biol, 2016, 17(1):163. doi: 10.1186/s13059-016-1021-1 URL
[19]	Arthur JC, Perez-Chanona E, Mühlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota[J]. Science, 2012, 338(6103):120-123. doi: 10.1126/science.1224820 URL
[20]	He Z, Gharaibeh RZ, Newsome RC, et al. Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin[J]. Gut, 2019, 68(2):289-300. doi: 10.1136/gutjnl-2018-317200 URL
[21]	Attene-Ramos MS, Wagner ED, Plewa MJ, et al. Evidence that hydrogen sulfide is a genotoxic agent[J]. Mol Cancer Res, 2006, 4(1):9-14. pmid: 16446402
[22]	Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models[J]. Exp Biol Med (Maywood), 2004, 229(7):586-597. doi: 10.1177/153537020422900702 URL
[23]	Münger K, Baldwin A, Edwards KM, et al. Mechanisms of human papillomavirus-induced oncogenesis[J]. J Virol, 2004, 78(21):11451-11460. pmid: 15479788
[24]	Miyoshi J, Chang EB. The gut microbiota and inflammatory bowel diseases[J]. Transl Res, 2017, 179:38-48. doi: S1931-5244(16)30095-0 pmid: 27371886
[25]	Aran D, Lasry A, Zinger A, et al. Widespread parainflammation in human cancer[J]. Genome Biol, 2016, 17(1):145. doi: 10.1186/s13059-016-0995-z URL
[26]	Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation[J]. Semin Cancer Biol, 2004, 14(6):453-471. doi: 10.1016/j.semcancer.2004.06.009 URL
[27]	Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment[J]. Cell Host Microbe, 2013, 14(2):207-215. doi: 10.1016/j.chom.2013.07.007 URL
[28]	Wu S, Rhee KJ, Zhang M, et al. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage[J]. J Cell Sci, 2007, 120(Pt 11):1944-1952. doi: 10.1242/jcs.03455 URL
[29]	Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin[J]. Cell Host Microbe, 2013, 14(2):195-206. doi: 10.1016/j.chom.2013.07.012 pmid: 23954158
[30]	Wang K, Wang J, Wei F, et al. Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy[J]. Front Immunol, 2017, 8:456. doi: 10.3389/fimmu.2017.00456 URL
[31]	Adolph TE, Tomczak MF, Niederreiter L, et al. Paneth cells as a site of origin for intestinal inflammation[J]. Nature, 2013, 503(7475):272-276. doi: 10.1038/nature12599 URL
[32]	Herfs M, Hubert P, Delvenne P. Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation?[J]. Trends Mol Med, 2009, 15(6):245-253. doi: 10.1016/j.molmed.2009.04.002 URL
[33]	Ali T, Kaitha S, Mahmood S, et al. Clinical use of anti-TNF therapy and increased risk of infections[J]. Drug Healthc Patient Saf, 2013, 5:79-99.
[34]	Couturier-Maillard A, Secher T, Rehman A, et al. NOD2-mediated dysbiosis predisposes mice to transmissible coli-tis and colorectal cancer[J]. J Clin Invest, 2013, 123(2):700-711. doi: 10.1172/JCI62236 pmid: 23281400
[35]	Levy M, Thaiss CA, Zeevi D, et al. Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling[J]. Cell, 2015, 163(6):1428-1443. doi: 10.1016/j.cell.2015.10.048 URL
[36]	Wynendaele E, Verbeke F, D'Hondt M, et al. Crosstalk between the microbiome and cancer cells by quorum sensing peptides[J]. Peptides, 2015, 64:40-48. doi: 10.1016/j.peptides.2014.12.009 pmid: 25559405
[37]	García-Castillo V, Sanhueza E, McNerney E, et al. Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle[J]. J Med Microbiol, 2016, 65(12):1347-1362. doi: 10.1099/jmm.0.000371 pmid: 27902422
[38]	Jungnickel C, Schmidt LH, Bittigkoffer L, et al. IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth[J]. Oncogene, 2017, 36(29):4182-4190. doi: 10.1038/onc.2017.28 pmid: 28346430
[39]	Jungnickel C, Wonnenberg B, Karabiber O, et al. Cigarette smoke-induced disruption of pulmonary barrier and bacterial translocation drive tumor-associated inflammation and growth[J]. Am J Physiol Lung Cell Mol Phy-siol, 2015, 309(6):L605-L613.
[40]	Ochoa CE, Mirabolfathinejad SG, Ruiz VA, et al. Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis[J]. Cancer Prev Res (Phila), 2011, 4(1):51-64. doi: 10.1158/1940-6207.CAPR-10-0180 URL
[41]	Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system[J]. Science, 2012, 336(6086):1268-1273. doi: 10.1126/science.1223490 pmid: 22674334
[42]	Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors[J]. Science, 2018, 359(6371):91-97. doi: 10.1126/science.aan3706 URL
[43]	Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J]. Immunity, 2015, 42(2):344-355. doi: 10.1016/j.immuni.2015.01.010 URL
[44]	Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses[J]. Nat Med, 2009, 15(9):1016-1022. doi: 10.1038/nm.2015 URL
[45]	Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis[J]. Science, 2013, 341(6145):569-573. doi: 10.1126/science.1241165 URL
[46]	Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells[J]. Nature, 2013, 504(7480):446-450. doi: 10.1038/nature12721 URL
[47]	O'Keefe SJ, Li JV, Lahti L, et al. Fat, fibre and cancer risk in African Americans and rural Africans[J]. Nat Commun, 2015, 6:6342. doi: 10.1038/ncomms7342 URL
[48]	Chang SH, Mirabolfathinejad SG, Katta H, et al. T helper 17 cells play a critical pathogenic role in lung cancer[J]. Proc Natl Acad Sci U S A, 2014, 111(15):5664-5669. doi: 10.1073/pnas.1319051111 pmid: 24706787
[49]	Cheng M, Qian L, Shen G, et al. Microbiota modulate tumoral immune surveillance in lung through a γδT17 immune cell-dependent mechanism[J]. Cancer Res, 2014, 74(15):4030-4041. doi: 10.1158/0008-5472.CAN-13-2462 pmid: 24947042
[50]	Jin C, Lagoudas GK, Zhao C, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells[J]. Cell, 2019, 176(5):998-1013. doi: 10.1016/j.cell.2018.12.040 URL
[51]	Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions[J]. Science, 2012, 336(6086):1262-1267. doi: 10.1126/science.1223813 pmid: 22674330
[52]	O'Keefe SJ. Diet, microorganisms and their metabolites, and colon cancer[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(12):691-706. doi: 10.1038/nrgastro.2016.165 URL
[53]	Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome[J]. Nature, 2013, 499(7456):97-101. doi: 10.1038/nature12347 URL
[54]	Singh N, Gurav A, Sivaprakasam S, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis[J]. Immunity, 2014, 40(1):128-139. doi: 10.1016/j.immuni.2013.12.007 URL
[55]	Elangovan S, Pathania R, Ramachandran S, et al. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival[J]. Cancer Res. 2014, 74(4):1166-1178.
[56]	Belcheva A, Irrazabal T, Robertson SJ, et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells[J]. Cell, 2014, 158(2):288-299. doi: 10.1016/j.cell.2014.04.051 URL
[57]	Xiao X, Cao Y, Chen H. Profiling and characterization of microRNAs responding to sodium butyrate treatment in A549 cells[J]. J Cell Biochem, 2018, 119(4):3563-3573. doi: 10.1002/jcb.26547 URL
[58]	Kim K, Kwon O, Ryu TY, et al. Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer[J]. Mol Med Rep, 2019, 20(2):1569-1574.
[59]	Scott AJ, Alexander JL, Merrifield CA, et al. Internatio-nal Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis[J]. Gut, 2019, 68(9):1624-1632. doi: 10.1136/gutjnl-2019-318556 URL

肺部微生态及其与肺癌关系的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 59

相关文章 15

编辑推荐

Metrics

本文评价

[1]	孙艳艳, 兰信堂. 肺癌颅脑转移患者接受放射治疗后前庭功能受损1例[J]. 诊断学理论与实践, 2022, 21(05): 632-634.
[2]	陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[3]	汤建平, 龚邦东. 干燥综合征的诊治现状、挑战和思考[J]. 诊断学理论与实践, 2022, 21(03): 291-298.
[4]	罗雅方, 徐倩玥, 余红. 尘螨在特应性皮炎中的致病机制及相关免疫治疗应用研究进展[J]. 诊断学理论与实践, 2021, 20(06): 592-595.
[5]	苏长青. 从基础研究到临床转化应用谈肝癌的诊治进展[J]. 诊断学理论与实践, 2021, 20(05): 427-433.
[6]	章淼滢, 罗飞宏. 儿童单基因糖尿病诊治进展及诊断策略[J]. 诊断学理论与实践, 2021, 20(03): 229-232.
[7]	徐琛莹, 许庆玲, 唐陈月, 俞丽芬. 上海40~59岁无症状人群结肠直肠腺瘤的检出率及其与胃息肉检出的关系[J]. 诊断学理论与实践, 2020, 19(05): 504-509.
[8]	吴歆, 耿旭强, 徐沪济. 多基因风险评分在复杂性状疾病中的应用进展[J]. 诊断学理论与实践, 2020, 19(05): 540-543.
[9]	徐兆平, 王浩飞. ZNF692基因在肾透明细胞癌中的表达及其与患者预后间关系的研究[J]. 诊断学理论与实践, 2020, 19(03): 292-296.
[10]	杜海磊, 陈聆, 罗方秀, 李勇, 程齐俭, 朱良纲, 杭钧彪. Beclin-1和Bcl-2表达与非小细胞肺癌患者病理特征及预后间关系的研究[J]. 诊断学理论与实践, 2020, 19(03): 258-263.
[11]	倪瀚文, 吴立群. 外泌体在心肌缺血及房颤诊治中的应用前景研究进展[J]. 诊断学理论与实践, 2020, 19(02): 199-202.
[12]	汪峰, 罗颖, 孙自镛. 结核病的实验诊断技术应用及流程规范化[J]. 诊断学理论与实践, 2019, 18(2): 121-126.
[13]	余红, 王一飞, 陈佳, 陈洁, 李斌. 青蒿素及其衍生物在皮肤疾病中的作用机制研究及临床应用[J]. 诊断学理论与实践, 2019, 18(2): 233-236.
[14]	魏坚, 高平进, 韩卫青. α7烟碱型乙酰胆碱受体激动剂对TGF-β1介导的血管外膜成纤维细胞表型转化影响的体外研究[J]. 诊断学理论与实践, 2019, 18(1): 56-60.
[15]	房莹, 吴东, 常春康. 癌基因与抑癌基因在伯基特淋巴瘤发生发展中的研究进展[J]. 诊断学理论与实践, 2019, 18(06): 630-633.